Natalizumab Re-Initiation of Dosing

Clinical trial NCT00306592 · COMPLETED

Trial details

NCT number: NCT00306592
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2006-03-01
Primary completion: 2007-12-01
Enrollment: 404

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.